{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T02:30:32Z","timestamp":1787020232629,"version":"build-2736575974"},"reference-count":72,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T00:00:00Z","timestamp":1758931200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T00:00:00Z","timestamp":1758931200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Pregnancy Childbirth"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Preeclampsia (PE), a grave obstetric complication, mandates the expeditious formulation of efficacious early diagnostic strategies. Accumulating evidence suggests that non - coding RNAs (ncRNAs), which are present in maternal circulation and placental tissues, display abnormal expression patterns in patients with PE, underscoring their potential as diagnostic biomarkers. This systematic review and meta - analysis intends to assess the diagnostic accuracy of ncRNAs for the detection of PE.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A comprehensive search was carried out across seven databases (China National Knowledge Infrastructure [CNKI], Wanfang Database, VIP Database, PubMed, Web of Science, Embase, and the Cochrane Library) up to December 25, 2024, to identify case - control and cohort studies exploring the diagnostic value of ncRNAs in PE. The quality of the studies was evaluated using the Quality Assessment of Diagnostic Accuracy Studies \u2212\u20092 (QUADAS \u2212\u20092) tool and the Newcastle - Ottawa Scale (NOS), and publication bias was assessed using Deeks\u2019 funnel plot. The pooled sensitivity (SEN), specificity (SPE), diagnostic odds ratio (DOR), and area under the curve (AUC) were computed using Review Manager 5.4 and Meta - DiSc 1.4.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Among the 2,201 identified studies, 40 fulfilled the inclusion criteria for qualitative synthesis. Forty - eight ncRNAs showed diagnostic potential, including 25 microRNAs (miRNAs), 9 long non - coding RNAs (lncRNAs), and 6 circular RNAs (circRNAs). The pooled sensitivity and specificity were 80% (95% confidence interval [CI]: 76\u201384%) and 82% (95% CI: 79\u201385%), respectively. Single miRNA assays presented superior diagnostic performance (sensitivity [SEN]: 85%, specificity [SPE]: 85%) in comparison to circRNAs (SEN: 80%, SPE: 79%). Notably, combinatorial panels consisting of 2\u20133 ncRNAs attained optimal diagnostic performance, with a sensitivity of 91% (95% CI: 88\u201394%), a specificity of 80% (95% CI: 76\u201384%), and an area under the curve (AUC) of 0.9418 (standard error [SE]\u2009=\u20090.0152).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Circulating ncRNAs exhibit significant potential as diagnostic biomarkers for PE, with multi-analyte panels providing improved diagnostic accuracy compared to single-marker strategies.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12884-025-08116-8","type":"journal-article","created":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T16:01:14Z","timestamp":1758988874000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Non-coding RNAs as diagnostic biomarkers for preeclampsia: a systematic review and meta-analysis"],"prefix":"10.1186","volume":"25","author":[{"given":"Jiayu","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qipeng","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yafei","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,9,27]]},"reference":[{"issue":"4","key":"8116_CR1","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1016\/j.bpobgyn.2011.01.006","volume":"25","author":"JA Hutcheon","year":"2011","unstructured":"Hutcheon JA, Lisonkova S, Joseph KS. Epidemiology of pre-eclampsia and the other hypertensive disorders of pregnancy. Best Pract Res Clin Obstet Gynaecol. 2011;25(4):391\u2013403. https:\/\/doi.org\/10.1016\/j.bpobgyn.2011.01.006.","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"issue":"11","key":"8116_CR2","doi-asserted-by":"publisher","first-page":"1297","DOI":"10.1007\/s10654-024-01157-x","volume":"39","author":"S Zhou","year":"2024","unstructured":"Zhou S, Zhou N, Zhang H, et al. A prospective multicenter birth cohort in China: pregnancy health atlas. Eur J Epidemiol. 2024;39(11):1297\u2013310. https:\/\/doi.org\/10.1007\/s10654-024-01157-x.","journal-title":"Eur J Epidemiol"},{"key":"8116_CR3","doi-asserted-by":"publisher","unstructured":"Global regional and national levels of maternal mortality,1990\u20132015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet. 2016;388(10053):1775\u2013812. https:\/\/doi.org\/10.1016\/S0140-6736(16)31470-2.","DOI":"10.1016\/S0140-6736(16)31470-2"},{"key":"8116_CR4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jri.2019.07.004","volume":"134","author":"AC Staff","year":"2019","unstructured":"Staff AC. The two-stage placental model of preeclampsia: an update. J Reprod Immunol. 2019;134:1\u201310. https:\/\/doi.org\/10.1016\/j.jri.2019.07.004.","journal-title":"J Reprod Immunol"},{"issue":"1","key":"8116_CR5","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.anclin.2016.09.009","volume":"35","author":"NK Dhariwal","year":"2017","unstructured":"Dhariwal NK, Lynde GC. Update in the management of patients with preeclampsia. Anesthesiol Clin. 2017;35(1):95\u2013106. https:\/\/doi.org\/10.1016\/j.anclin.2016.09.009.","journal-title":"Anesthesiol Clin"},{"issue":"1","key":"8116_CR6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1097\/AOG.0000000000003018","volume":"133","author":"ACOG Practice Bulletin No","year":"2019","unstructured":"ACOG Practice Bulletin No. 202: gestational hypertension and preeclampsia. Obstet Gynecol. 2019;133(1):1. https:\/\/doi.org\/10.1097\/AOG.0000000000003018.","journal-title":"Obstet Gynecol"},{"issue":"2","key":"8116_CR7","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1111\/j.1479-828x.2000.tb01136.x","volume":"40","author":"MA Brown","year":"2000","unstructured":"Brown MA, Hague WM, Higgins J, et al. The detection, investigation and management of hypertension in pregnancy: executive summary. Aust N Z J Obstet Gynaecol. 2000;40(2):133\u20138. https:\/\/doi.org\/10.1111\/j.1479-828x.2000.tb01136.x.","journal-title":"Aust N Z J Obstet Gynaecol"},{"issue":"1","key":"8116_CR8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1095\/biolreprod.102.014977","volume":"69","author":"P Kaufmann","year":"2003","unstructured":"Kaufmann P, Black S, Huppertz B. Endovascular trophoblast invasion: implications for the pathogenesis of intrauterine growth retardation and preeclampsia. Biol Reprod. 2003;69(1):1\u20137. https:\/\/doi.org\/10.1095\/biolreprod.102.014977.","journal-title":"Biol Reprod"},{"issue":"04","key":"8116_CR9","first-page":"352","volume":"37","author":"X Li","year":"2024","unstructured":"Li X, Zhang C, Lin W. Clinical significance and diagnostic value of long non-coding RNA LOC152742 expression in peripheral blood of patients with active pulmonary tuberculosis. Infect Disease Inform. 2024;37(04):352\u20135.","journal-title":"Infect Disease Inform"},{"issue":"15","key":"8116_CR10","doi-asserted-by":"publisher","first-page":"e35663","DOI":"10.1016\/j.heliyon.2024.e35663","volume":"10","author":"Q Shi","year":"2024","unstructured":"Shi Q, Wang Q, Mao K, Liu Z, Wang R. Microrna-2861 regulates the proliferation and apoptosis of human retinal vascular endothelial cells treated with high glucose by targeting NDUFB7. Heliyon. 2024;10(15):e35663. https:\/\/doi.org\/10.1016\/j.heliyon.2024.e35663.","journal-title":"Heliyon"},{"key":"8116_CR11","doi-asserted-by":"publisher","first-page":"11295","DOI":"10.1038\/srep11295","volume":"5","author":"NI Hornick","year":"2015","unstructured":"Hornick NI, Huan J, Doron B, et al. Serum exosome microRNA as a minimally-invasive early biomarker of AML. Sci Rep. 2015;5:11295. https:\/\/doi.org\/10.1038\/srep11295.","journal-title":"Sci Rep"},{"key":"8116_CR12","doi-asserted-by":"publisher","DOI":"10.3390\/cells11152428","author":"M Ogoyama","year":"2022","unstructured":"Ogoyama M, Takahashi H, Suzuki H, et al. Non-coding RNAs and prediction of preeclampsia in the first trimester of pregnancy. Cells. 2022. https:\/\/doi.org\/10.3390\/cells11152428.","journal-title":"Cells"},{"key":"8116_CR13","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.placenta.2024.06.009","volume":"157","author":"WR Cooke","year":"2024","unstructured":"Cooke WR, Jones GD, Redman CW, Vatish M. Small RNAs in the pathogenesis of preeclampsia. Placenta. 2024;157:21\u20137. https:\/\/doi.org\/10.1016\/j.placenta.2024.06.009.","journal-title":"Placenta"},{"key":"8116_CR14","doi-asserted-by":"publisher","DOI":"10.3390\/ijms20112837","author":"C Apicella","year":"2019","unstructured":"Apicella C, Ruano CSM, Mehats C, Miralles F, Vaiman D. The role of epigenetics in placental development and the etiology of preeclampsia. Int J Mol Sci. 2019. https:\/\/doi.org\/10.3390\/ijms20112837.","journal-title":"Int J Mol Sci"},{"issue":"1","key":"8116_CR15","doi-asserted-by":"publisher","first-page":"28","DOI":"10.2174\/2211536607666180813123303","volume":"8","author":"G Skalis","year":"2019","unstructured":"Skalis G, Katsi V, Miliou A, et al. MicroRNAs Preeclampsia Microrna. 2019;8(1):28\u201335. https:\/\/doi.org\/10.2174\/2211536607666180813123303.","journal-title":"MicroRNAs Preeclampsia Microrna"},{"key":"8116_CR16","doi-asserted-by":"publisher","first-page":"7237495","DOI":"10.1155\/2019\/7237495","volume":"2019","author":"N Jia","year":"2019","unstructured":"Jia N, Li J. Role of circular RNAs in preeclampsia. Dis Markers. 2019;2019:7237495. https:\/\/doi.org\/10.1155\/2019\/7237495.","journal-title":"Dis Markers"},{"issue":"10","key":"8116_CR17","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.2174\/1389450118666170404160000","volume":"18","author":"X Song","year":"2017","unstructured":"Song X, Luo X, Gao Q, et al. Dysregulation of LncRNAs in placenta and pathogenesis of preeclampsia. Curr Drug Targets. 2017;18(10):1165\u201370. https:\/\/doi.org\/10.2174\/1389450118666170404160000.","journal-title":"Curr Drug Targets"},{"key":"8116_CR18","doi-asserted-by":"publisher","DOI":"10.3390\/jcm14062003","author":"A Gerede","year":"2025","unstructured":"Gerede A, Stavros S, Danavasi M, et al. Micrornas in preeclampsia: bridging diagnosis and treatment. J Clin Med. 2025. https:\/\/doi.org\/10.3390\/jcm14062003.","journal-title":"J Clin Med"},{"issue":"7","key":"8116_CR19","doi-asserted-by":"publisher","first-page":"1698","DOI":"10.1111\/jog.15297","volume":"48","author":"N Wei","year":"2022","unstructured":"Wei N, Song H. Circ-0002814 participates in proliferation and migration through miR-210 and FUS\/VEGF pathway of preeclampsia. J Obstet Gynaecol Res. 2022;48(7):1698\u2013709. https:\/\/doi.org\/10.1111\/jog.15297.","journal-title":"J Obstet Gynaecol Res"},{"issue":"1","key":"8116_CR20","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1530\/REP-19-0614","volume":"160","author":"R Wang","year":"2020","unstructured":"Wang R, Zou L. Downregulation of LncRNA-MEG3 promotes HTR8\/SVneo cells apoptosis and attenuates its migration by repressing Notch1 signal in preeclampsia. Reproduction. 2020;160(1):21\u20139. https:\/\/doi.org\/10.1530\/REP-19-0614.","journal-title":"Reproduction"},{"key":"8116_CR21","doi-asserted-by":"publisher","first-page":"n71","DOI":"10.1136\/bmj.n71","volume":"372","author":"MJ Page","year":"2021","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372:n71. https:\/\/doi.org\/10.1136\/bmj.n71.","journal-title":"BMJ"},{"key":"8116_CR22","unstructured":"Cochrane Training. Cochrane Handbook for Systematic Reviews of Interventions. Version 6.3. 2024. https:\/\/training.cochrane.org\/handbook"},{"issue":"13","key":"8116_CR23","doi-asserted-by":"publisher","first-page":"2113","DOI":"10.1111\/1471-0528.13897","volume":"123","author":"Y Zhang","year":"2016","unstructured":"Zhang Y, Yang H, Long Y, Li W. Circular RNA in blood corpuscles combined with plasma protein factor for early prediction of pre-eclampsia. BJOG. 2016;123(13):2113\u20138. https:\/\/doi.org\/10.1111\/1471-0528.13897.","journal-title":"BJOG"},{"issue":"1","key":"8116_CR24","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1186\/s12884-020-03345-5","volume":"20","author":"Y Zhang","year":"2020","unstructured":"Zhang Y, Yang H, Zhang Y, Shi J, Chen R. CircCRAMP1L is a novel biomarker of preeclampsia risk and may play a role in preeclampsia pathogenesis via regulation of the MSP\/RON axis in trophoblasts. BMC Pregnancy Childbirth. 2020;20(1):652. https:\/\/doi.org\/10.1186\/s12884-020-03345-5.","journal-title":"BMC Pregnancy Childbirth"},{"issue":"6","key":"8116_CR25","doi-asserted-by":"publisher","first-page":"2576","DOI":"10.1159\/000489685","volume":"46","author":"M Jiang","year":"2018","unstructured":"Jiang M, Lash GE, Zhao X, et al. CircRNA-0004904, CircRNA-0001855, and PAPP-A: potential novel biomarkers for the prediction of preeclampsia. Cell Physiol Biochem. 2018;46(6):2576\u201386. https:\/\/doi.org\/10.1159\/000489685.","journal-title":"Cell Physiol Biochem"},{"key":"8116_CR26","doi-asserted-by":"publisher","DOI":"10.3389\/fmolb.2021.652250","volume":"8","author":"D Chen","year":"2021","unstructured":"Chen D, He B, Zheng P, et al. Identification of mRNA-, circRNA- and lncRNA- associated CeRNA networks and potential biomarkers for preeclampsia from umbilical vein endothelial cells. Front Mol Biosci. 2021;8:652250.","journal-title":"Front Mol Biosci"},{"issue":"01","key":"8116_CR27","first-page":"15","volume":"42","author":"Q Ye","year":"2021","unstructured":"Ye Q, Zhai G, Wu Y, Yang H. Expression levels and clinical significance of LncRNAMALAT1 and miR-206 in plasma exosomes of preeclampsia pregnant women. Anhui Med J. 2021;42(01):15\u201320.","journal-title":"Anhui Med J"},{"issue":"03","key":"8116_CR28","first-page":"17","volume":"14","author":"D Chen","year":"2022","unstructured":"Chen D, Yang X, Cheng W. The predictive value of lnc-C17orf64-1:1 in peripheral blood in early pregnancy for preeclampsia. Chin J Fam Plann Gynecol. 2022;14(03):17\u201320.","journal-title":"Chin J Fam Plann Gynecol"},{"issue":"02","key":"8116_CR29","first-page":"155","volume":"37","author":"H Gao","year":"2024","unstructured":"Gao H, Gao J, Zhang X, et al. Value of serum LncRNA DUXAP8 and miR-24-3p in the diagnosis of preeclampsia and the evaluation of pregnancy outcomes. Med Res Battlef Casualty Care. 2024;37(02):155\u201360.","journal-title":"Med Res Battlef Casualty Care"},{"issue":"10","key":"8116_CR30","first-page":"1381","volume":"21","author":"Y Zhang","year":"2024","unstructured":"Zhang Y, Li Y, Zhou J. Expression of serum IGF-1 and LncRNA TCL6 in pregnant women with severe preeclampsia and its predictive value for adverse pregnancy outcome. Lab Med Clin. 2024;21(10):1381\u20136.","journal-title":"Lab Med Clin"},{"issue":"10","key":"8116_CR31","first-page":"2171","volume":"31","author":"C Huo","year":"2023","unstructured":"Huo C, Xie L, Zhang A. Expression and clinical significance of LncRNA HIF1A-AS1 in pregnant women with preeclampsia in Qinghai area. Chin J Birth Health Hered. 2023;31(10):2171\u20134.","journal-title":"Chin J Birth Health Hered"},{"issue":"6","key":"8116_CR32","first-page":"79","volume":"10","author":"D Chen","year":"2018","unstructured":"Chen D, Liu G, Liang H, Yu H, Peng S. Expression levels and clinical significances of miRNA-206 and IGF-1 in the serum of pregnant women with early onset preeclampsia. Chin J Fam Plann Gynecol. 2018;10(6):79\u201383.","journal-title":"Chin J Fam Plann Gynecol"},{"issue":"7","key":"8116_CR33","first-page":"868","volume":"48","author":"Y Song","year":"2023","unstructured":"Song Y, Zhou X, Xu Y, Zhan F. Study on the relationship between LncRNA SNHG5 and miR-132-3p expression in placenta tissue of preeclampsia patients. J Bengbu Med Coll. 2023;48(7):868\u201372.","journal-title":"J Bengbu Med Coll"},{"issue":"11","key":"8116_CR34","first-page":"1589","volume":"32","author":"D Zhang","year":"2021","unstructured":"Zhang D, Yang L, Li Z, Zhang H. Differential expression of lncRNA MALAT1in normal pregnancy and preeclampsia and its clinical significance. Chin J Woman Child Health Res. 2021;32(11):1589\u201394.","journal-title":"Chin J Woman Child Health Res"},{"issue":"6","key":"8116_CR35","doi-asserted-by":"publisher","first-page":"429","DOI":"10.5603\/GP.a2022.0016","volume":"94","author":"Z Liang","year":"2023","unstructured":"Liang Z, Wang L. Expression and clinical significance of LncRNA NORAD in patients with gestational hypertension. Ginekol Pol. 2023;94(6):429\u201334. https:\/\/doi.org\/10.5603\/GP.a2022.0016.","journal-title":"Ginekol Pol"},{"key":"8116_CR36","doi-asserted-by":"publisher","first-page":"147932","DOI":"10.1016\/j.gene.2023.147932","volume":"893","author":"MA Abbas","year":"2024","unstructured":"Abbas MA, Abo Shady HM, Ahmed Elshafey OH, Al-Sheikh NM. Association between expression levels of p53, miRNA-21, and lncRNA-TCL6 and the risk of preeclampsia in pregnant women. Gene. 2024;893:147932. https:\/\/doi.org\/10.1016\/j.gene.2023.147932.","journal-title":"Gene"},{"issue":"12","key":"8116_CR37","first-page":"3408","volume":"44","author":"H Yu","year":"2023","unstructured":"Yu H, Lin J, Huang T, et al. Serum miR-181a and C-reactive protein expressions in patients with preeclampsia and their clinical significance in the third trimester of pregnancy. Jilin Med J. 2023;44(12):3408\u201311.","journal-title":"Jilin Med J"},{"issue":"10","key":"8116_CR38","first-page":"43","volume":"35","author":"Z Liu","year":"2024","unstructured":"Liu Z, Li S, Qi G, Jiang T. Serum levels of miR-20b and miR-4443 of patients with severe preeclampsia and their relationships with adverse pregnancy outcomes. Chin J Woman Child Health Res. 2024;35(10):43\u20139.","journal-title":"Chin J Woman Child Health Res"},{"issue":"08","key":"8116_CR39","first-page":"616","volume":"29","author":"S Niu","year":"2020","unstructured":"Niu S, Liu N, Xin H, et al. Clinical significance of miR-195 and miR-204 expression in peripheral serum of preeclampsia patients. Mod Adv Obstet Gynecol. 2020;29(08):616\u20138.","journal-title":"Mod Adv Obstet Gynecol"},{"issue":"05","key":"8116_CR40","first-page":"1012","volume":"29","author":"H Wan","year":"2021","unstructured":"Wan H, Zhou Y. Value of the miR-101expression during the second trimester of pregnancy for predicting their preeclampsia occurrence. Chin J Fam Plann. 2021;29(05):1012\u20135.","journal-title":"Chin J Fam Plann"},{"issue":"02","key":"8116_CR41","first-page":"32","volume":"38","author":"H Kang","year":"2023","unstructured":"Kang H, Zhang L, Ma X, Cui Z. Study on the expression level of serum miR-29a-3p and VEGFA in early pregnancy and its predictive value for preeclampsia. Mod J Lab Med. 2023;38(02):32\u20136.","journal-title":"Mod J Lab Med"},{"issue":"12","key":"8116_CR42","first-page":"105","volume":"31","author":"A Zhang","year":"2022","unstructured":"Zhang A, Zhao D, Huo C, Xie L. The predictive value of miR-210,hypoxia-inducible factor-1\u03b1combined with soluble vascular endothelial growth factor receptor1\/placental growth factor ratio in pregnant women Witn preeclamsia in Qinghai. Chin J Sexol. 2022;31(12):105\u20139.","journal-title":"Chin J Sexol"},{"issue":"21","key":"8116_CR43","first-page":"4141","volume":"38","author":"X Sun","year":"2023","unstructured":"Sun X, Wang J, Lian Y. Expression and role of microRNA-103a and brain-derived neurotrophic factor in the serum of pregnant women with preeclampsia. Chin J Matern Child Health. 2023;38(21):4141\u20134.","journal-title":"Chin J Matern Child Health"},{"issue":"12","key":"8116_CR44","first-page":"1311","volume":"49","author":"Y Wang","year":"2021","unstructured":"Wang Y, Li C. The predictive value of microRNA-18a combined with uterine artery blood flow parameters for early-onset preeclampsia. Tianjin Med J. 2021;49(12):1311\u20135.","journal-title":"Tianjin Med J"},{"issue":"16","key":"8116_CR45","first-page":"3812","volume":"34","author":"H Han","year":"2019","unstructured":"Han H. To investigate the predictive value of changes in the level of target miRNAs associated with soluble fms-like cool acid kinase 1 in preeclampsia. Chin J Matern Child Health. 2019;34(16):3812\u20136.","journal-title":"Chin J Matern Child Health"},{"issue":"23","key":"8116_CR46","first-page":"4028","volume":"30","author":"Q Wang","year":"2015","unstructured":"Wang Q, Zhao C, Xia L, Zhu H. The value of changes in serum microRNA-152 and soluble human leukocyte antigen G levels in the second trimester of pregnancy in predicting preeclampsia. Chin J Matern Child Health. 2015;30(23):4028\u201330.","journal-title":"Chin J Matern Child Health"},{"issue":"6","key":"8116_CR47","first-page":"7288","volume":"13","author":"Y Jin","year":"2021","unstructured":"Jin Y, Jia T, Wu X, et al. The predictive value of miR-210 disorder complicating pregnancy. Am J Transl Res. 2021;13(6):7288\u201393.","journal-title":"Am J Transl Res"},{"issue":"13","key":"8116_CR48","first-page":"2446","volume":"38","author":"X Wu","year":"2023","unstructured":"Wu X, Zhou H, Zhou H. Expression and correlation analysis of STOX1Syncytin-1miR-29b in early-onset preeclampsia. Chin J Matern Child Health. 2023;38(13):2446\u20139.","journal-title":"Chin J Matern Child Health"},{"key":"8116_CR49","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.preghy.2019.05.013","volume":"17","author":"K Dong","year":"2019","unstructured":"Dong K, Zhang X, Ma L, et al. Downregulations of circulating miR-31 and miR-21 are associated with preeclampsia. Pregnancy Hypertens. 2019;17:59\u201363.","journal-title":"Pregnancy Hypertens"},{"issue":"8","key":"8116_CR50","doi-asserted-by":"publisher","first-page":"3537","DOI":"10.1080\/01443615.2022.2153022","volume":"42","author":"W Ning","year":"2022","unstructured":"Ning W, Chen Y, Chen Y, et al. Correlation and predictive value of serum miR-146b-5p expression during the first trimester of pregnancy with pre-eclampsia. J Obstet Gynaecol. 2022;42(8):3537\u201344. https:\/\/doi.org\/10.1080\/01443615.2022.2153022.","journal-title":"J Obstet Gynaecol"},{"key":"8116_CR51","doi-asserted-by":"publisher","DOI":"10.1186\/s12884-022-04785-x","author":"X He","year":"2022","unstructured":"He X, Ding D. High miR-200a-3p expression has high diagnostic values for hypertensive disorders complicating pregnancy and predicts adverse pregnancy outcomes. BMC Pregnancy Childbirth. 2022. https:\/\/doi.org\/10.1186\/s12884-022-04785-x.","journal-title":"BMC Pregnancy Childbirth"},{"key":"8116_CR52","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0171756","author":"I Hromadnikova","year":"2017","unstructured":"Hromadnikova I, Kotlabova K, Ivankova K, Krofta L. First trimester screening of circulating C19MC microRNAs and the evaluation of their potential to predict the onset of preeclampsia and IUGR. PLoS One. 2017. https:\/\/doi.org\/10.1371\/journal.pone.0171756.","journal-title":"PLoS One"},{"key":"8116_CR53","doi-asserted-by":"publisher","DOI":"10.1186\/s12916-022-02495-x","volume":"20","author":"S Bao","year":"2022","unstructured":"Bao S, Zhou T, Yan C, et al. A blood-based miRNA signature for early non-invasive diagnosis of preeclampsia. BMC Med. 2022;20:303. https:\/\/doi.org\/10.1186\/s12916-022-02495-x.","journal-title":"BMC Med"},{"key":"8116_CR54","doi-asserted-by":"publisher","DOI":"10.1186\/s13148-018-0482-3","volume":"10","author":"X Hu","year":"2018","unstructured":"Hu X, Ao J, Li X, et al. Competing endogenous RNA expression profiling in pre-eclampsia identifies hsa_circ_0036877 as a potential novel blood biomarker for early pre-eclampsia. Clin Epigenetics. 2018;10:48. https:\/\/doi.org\/10.1186\/s13148-018-0482-3.","journal-title":"Clin Epigenetics"},{"issue":"5","key":"8116_CR55","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1093\/biolre\/ioy034","volume":"98","author":"Y Bai","year":"2018","unstructured":"Bai Y, Rao H, Chen W, et al. Profiles of circular RNAs in human placenta and their potential roles related to preeclampsia. Biol Reprod. 2018;98(5):705\u201312. https:\/\/doi.org\/10.1093\/biolre\/ioy034.","journal-title":"Biol Reprod"},{"issue":"1","key":"8116_CR56","doi-asserted-by":"publisher","first-page":"e0190654","DOI":"10.1371\/journal.pone.0190654","volume":"13","author":"EE Winger","year":"2018","unstructured":"Winger EE, Reed JL, Ji X, Nicolaides K. Peripheral blood cell MicroRNA quantification during the first trimester predicts preeclampsia: proof of concept. PLoS One. 2018;13(1):e0190654. https:\/\/doi.org\/10.1371\/journal.pone.0190654.","journal-title":"PLoS One"},{"issue":"2","key":"8116_CR57","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1080\/10641963.2016.1210619","volume":"39","author":"Y Zhang","year":"2017","unstructured":"Zhang Y, Huang G, Zhang Y, et al. Mir-942 decreased before 20 weeks gestation in women with preeclampsia and was associated with the pathophysiology of preeclampsia in vitro. Clin Exp Hypertens. 2017;39(2):108\u201313. https:\/\/doi.org\/10.1080\/10641963.2016.1210619.","journal-title":"Clin Exp Hypertens"},{"issue":"1","key":"8116_CR58","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-73783-w","volume":"10","author":"C Whigham","year":"2020","unstructured":"Whigham C, MacDonald TM, Walker SP, et al. Micrornas 363 and 149 are differentially expressed in the maternal circulation preceding a diagnosis of preeclampsia. Sci Rep. 2020;10(1):18077. https:\/\/doi.org\/10.1038\/s41598-020-73783-w.","journal-title":"Sci Rep"},{"key":"8116_CR59","doi-asserted-by":"publisher","DOI":"10.1016\/j.yexmp.2021.104618","volume":"119","author":"X Zhao","year":"2021","unstructured":"Zhao X, Wang Y, Li L, et al. Predictive value of 4-hydroxyglutamate and miR-149-5p on eclampsia. Exp Mol Pathol. 2021;119:104618. https:\/\/doi.org\/10.1016\/j.yexmp.2021.104618.","journal-title":"Exp Mol Pathol"},{"key":"8116_CR60","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.abb.2018.09.023","volume":"659","author":"TMK Motawi","year":"2018","unstructured":"Motawi TMK, Sabry D, Maurice NW, Rizk SM. Role of mesenchymal stem cells exosomes derived micrornas; miR-136, miR-494 and miR-495 in pre-eclampsia diagnosis and evaluation. Arch Biochem Biophys. 2018;659:13\u201321. https:\/\/doi.org\/10.1016\/j.abb.2018.09.023.","journal-title":"Arch Biochem Biophys"},{"key":"8116_CR61","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/j.preghy.2019.04.004","volume":"17","author":"M Hocaoglu","year":"2019","unstructured":"Hocaoglu M, Demirer S, Senturk H, Turgut A, Komurcu-Bayrak E. Differential expression of candidate circulating MicroRNAs in maternal blood leukocytes of the patients with preeclampsia and gestational diabetes mellitus. Pregnancy Hypertens. 2019;17:5\u201311. https:\/\/doi.org\/10.1016\/j.preghy.2019.04.004.","journal-title":"Pregnancy Hypertens"},{"issue":"22","key":"8116_CR62","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000020319","volume":"99","author":"C Sheng","year":"2020","unstructured":"Sheng C, Zhao Y, Zhu L. Down-regulation of EDN1 gene expression by circulating miR-206 is associated with risk of preeclampsia. Medicine. 2020;99(22):e20319. https:\/\/doi.org\/10.1097\/MD.0000000000020319.","journal-title":"Medicine"},{"issue":"6","key":"8116_CR63","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1002\/mrd.23147","volume":"86","author":"H Tao","year":"2019","unstructured":"Tao H, Liu X, Liu X, et al. LncRNA MEG3 inhibits trophoblast invasion and trophoblast-mediated VSMC loss in uterine spiral artery remodeling. Mol Reprod Dev. 2019;86(6):686\u201395. https:\/\/doi.org\/10.1002\/mrd.23147.","journal-title":"Mol Reprod Dev"},{"issue":"1","key":"8116_CR64","doi-asserted-by":"publisher","first-page":"1495","DOI":"10.1038\/s41467-019-09482-6","volume":"10","author":"P Zhang","year":"2019","unstructured":"Zhang P, Cao L, Zhou R, Yang X, Wu M. The lncrna Neat1 promotes activation of inflammasomes in macrophages. Nat Commun. 2019;10(1):1495. https:\/\/doi.org\/10.1038\/s41467-019-09482-6.","journal-title":"Nat Commun"},{"issue":"7441","key":"8116_CR65","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1038\/nature11928","volume":"495","author":"S Memczak","year":"2013","unstructured":"Memczak S, Jens M, Elefsinioti A, et al. Circular RNAs are a large class of animal RNAs with regulatory potency. Nature. 2013;495(7441):333\u20138. https:\/\/doi.org\/10.1038\/nature11928.","journal-title":"Nature"},{"key":"8116_CR66","doi-asserted-by":"publisher","DOI":"10.3390\/cells8111344","author":"X Hu","year":"2019","unstructured":"Hu X, Zhang L. Micrornas in uteroplacental vascular dysfunction. Cells. 2019. https:\/\/doi.org\/10.3390\/cells8111344.","journal-title":"Cells"},{"key":"8116_CR67","doi-asserted-by":"publisher","unstructured":"Munjas J, Sopic M, Stefanovic A, et al. Non-Coding RNAs in Preeclampsia-Molecular mechanisms and diagnostic potential. Int J Mol Sci. 2021;22(19). https:\/\/doi.org\/10.3390\/ijms221910652.","DOI":"10.3390\/ijms221910652"},{"issue":"10","key":"8116_CR68","first-page":"43","volume":"35","author":"Z Liu","year":"2024","unstructured":"Liu Z, Li S, Qi G, Jiang T. The predictive value of lnc-C17orf64-1:1 in peripheral blood in early pregnancy for preeclampsia. Chin Matern Child Health Res. 2024;35(10):43\u20139.","journal-title":"Chin Matern Child Health Res"},{"issue":"10","key":"8116_CR69","first-page":"1063","volume":"21","author":"L Xu","year":"2022","unstructured":"Xu L, Wang R, Zhang Z, Huang S, Luo S. Value of serum LncRNA DUXAP8 and miR-24-3p in the diagnosis of preeclampsia and the evaluation of pregnancy outcomes. Chin J Diffic Complicat Cases. 2022;21(10):1063\u20138.","journal-title":"Chin J Diffic Complicat Cases"},{"key":"8116_CR70","doi-asserted-by":"publisher","DOI":"10.1016\/j.bpobgyn.2024.102480","volume":"94","author":"JM Roberts","year":"2024","unstructured":"Roberts JM. Preeclampsia epidemiology(ies) and pathophysiology(ies). Best Pract Res Clin Obstet Gynaecol. 2024;94:102480. https:\/\/doi.org\/10.1016\/j.bpobgyn.2024.102480.","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"issue":"8","key":"8116_CR71","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1097\/OGX.0b013e3182331028","volume":"66","author":"D Raymond","year":"2011","unstructured":"Raymond D, Peterson E. A critical review of early-onset and late-onset preeclampsia. Obstet Gynecol Surv. 2011;66(8):497\u2013506. https:\/\/doi.org\/10.1097\/OGX.0b013e3182331028.","journal-title":"Obstet Gynecol Surv"},{"key":"8116_CR72","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.placenta.2022.12.009","volume":"132","author":"VAF Freire","year":"2023","unstructured":"Freire VAF, Melo ADD, Santos HDL, Barros-Pinheiro M. Evaluation of oxidative stress markers in subtypes of preeclampsia: a systematic review and meta-analysis. Placenta. 2023;132:55\u201367. https:\/\/doi.org\/10.1016\/j.placenta.2022.12.009.","journal-title":"Placenta"}],"container-title":["BMC Pregnancy and Childbirth"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12884-025-08116-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12884-025-08116-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12884-025-08116-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T16:01:18Z","timestamp":1758988878000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpregnancychildbirth.biomedcentral.com\/articles\/10.1186\/s12884-025-08116-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,27]]},"references-count":72,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["8116"],"URL":"https:\/\/doi.org\/10.1186\/s12884-025-08116-8","relation":{},"ISSN":["1471-2393"],"issn-type":[{"value":"1471-2393","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,27]]},"assertion":[{"value":"27 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 September 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"\u00a0Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"949"}}